Loading…
Bio-Rad Laboratories, Inc. is projected to rise to $353.10 by 2027, a +19% move from its current price of $296.11. BIO is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $290.31 | $296.36 | $302.55 | +0.09% |
| Jul 13 | $288.08 | $296.62 | $305.41 | +0.17% |
| Jul 14 | $286.44 | $296.87 | $307.68 | +0.26% |
| Jul 15 | $285.11 | $297.13 | $309.66 | +0.34% |
| Jul 16 | $283.96 | $297.38 | $311.44 | +0.43% |
| Jul 17 | $282.96 | $297.64 | $313.08 | +0.52% |
| Jul 18 | $282.05 | $297.89 | $314.62 | +0.60% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $282.05 | $297.89 | $314.62 | +0.60% |
| Week 2 | $277.40 | $299.69 | $323.76 | +1.21% |
| Week 3 | $274.27 | $301.49 | $331.42 | +1.82% |
| Week 4 | $271.91 | $303.31 | $338.33 | +2.43% |
| Week 5 | $270.04 | $305.13 | $344.79 | +3.05% |
| Week 6 | $268.52 | $306.97 | $350.93 | +3.67% |
| Week 7 | $267.25 | $308.82 | $356.85 | +4.29% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Bio‑Rad Laboratories, Inc. is a healthcare company that develops, manufactures, and distributes life science research and clinical diagnostic products. It serves customers across the United States, Europe, Asia, Canada, Latin America, and other international markets, operating through two segments: Life Science and Clinical Diagnostics.
The Life Science segment provides instruments, systems, reagents, and consumables used to separate, purify, characterize, and quantify biological materials such as cells, proteins, and nucleic acids for research, biopharmaceutical manufacturing, quality control, food safety, and education. Bio‑Rad Laboratories was founded in 1952 and is headquartered in Hercules, California.
Bio‑Rad Laboratories, Inc. (BIO) is a healthcare stock with current price $298.29 and a market cap of $7.98B, ranking 1053 by market size. The stock’s price outlook is reflected in a multi‑year forecast with a neutral start in 2026 and bullish momentum thereafter. The forecast shows a path of rising averages and expanding upside through 2050.
A major floor 18.4% below — a decisive break under it would weaken the trend.
The nearest floor, 8.7% below — buyers have tended to step in here.
The nearest ceiling, 7.5% above — a clean break opens room to run.
A major ceiling 15.8% above — clearing it would confirm fresh momentum.
Key BIO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BIO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $292.98 | Buy | $294.00 | Buy |
| MA 10 | $294.85 | Buy | $293.17 | Buy |
| MA 20 | $290.15 | Buy | $291.90 | Buy |
| MA 50 | $283.58 | Buy | $288.22 | Buy |
| MA 100 | $280.41 | Buy | $286.92 | Buy |
| MA 200 | $294.17 | Buy | $287.49 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 53.75 | Neutral |
| Stoch RSI (14) | 78.42 | Neutral |
| CCI (20) | 62.31 | Neutral |
| Williams %R (14) | -15.36 | Info |
| MACD (12,26,9) | 0.06 | Buy |
| ROC (12) | 9.54 | Buy |
| Bollinger %B (20,2) | 0.70 | Neutral |
| Stochastic %K (14) | 84.64 | Sell |
| TRIX (15) | 0.09 | Buy |
| Awesome (5,34) | -1.38 | Sell |
| Ultimate (7,14,28) | 53.86 | Neutral |
| Momentum (10) | -2.18 | Sell |
| Aroon Osc (25) | -48.00 | Sell |
| Hull MA (9) | 291.44 | Buy |
| ADX (14) | 11.89 | Neutral |
| ATR (14) | 5.32 | Info |
The 30‑day technical picture is described as bullish. The RSI(14) reading is 60, with the price above the SMA50 of $283.25 and above the SMA200 of $293.55. Near‑term support is at $243.51 and resistance at $318.22. The 30‑day price range spans from $255.92 to $347.67, indicating a period of notable movement within that window.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $241.71 | $296.11 | $402.52 | 0% | Neutral | |
| $287.45 | $353.10 | $454.73 | +19% | Neutral | |
| $305.00 | $382.43 | $506.97 | +29% | Bullish | |
| $337.70 | $430.66 | $584.08 | +45% | Bullish | |
| $336.19 | $435.14 | $601.66 | +47% | Bullish | |
| $385.98 | $506.37 | $712.09 | +71% | Bullish | |
| $473.30 | $628.71 | $897.71 | +112% | Bullish | |
| $495.15 | $665.43 | $963.40 | +125% | Bullish | |
| $519.61 | $706.04 | $1,035.34 | +138% | Bullish | |
| $537.71 | $738.34 | $1,095.68 | +149% | Bullish | |
| $807.30 | $1,161.91 | $1,813.12 | +292% | Bullish | |
| $1,405.98 | $2,189.33 | $3,679.59 | +639% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $241.71 | $296.11 | $355.18 | +0.00% |
| August 2026 | $266.30 | $312.32 | $374.66 | +5.47% |
| September 2026 | $271.60 | $320.21 | $387.38 | +2.53% |
| October 2026 | $268.16 | $317.56 | $386.94 | -0.83% |
| November 2026 | $268.31 | $318.96 | $390.97 | +0.44% |
| December 2026 | $273.74 | $326.56 | $402.52 | +2.39% |
Click any year to see its month-by-month BIO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The BIO price prediction for 2026 points to an average of $296.11 (low $241.71, high $402.52) — a potential gain of 0% on today's $296.11. A consolidation phase looks the most probable path here.
In 2027, BIO is projected to trade between $287.45 and $454.73, averaging $353.10 — a potential gain of +19% from today's $296.11. That is up +19% on the projected 2026 average. Price action looks broadly range-bound.
Bio-Rad Laboratories, Inc.'s 2028 outlook centres on $382.43, within a $305.00 to $506.97 range. That is up +8% on the projected 2027 average. That marks a +29% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, BIO could reach as high as $584.08, with a base case around $430.66 and support toward $337.70 — roughly +45% from $296.11. Momentum favours further upside here.
Expect BIO to range from $336.19 to $601.66 through 2030. The $435.14 average target implies a +47% move from current prices. That is up +1% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The BIO price prediction for 2031 points to an average of $506.37 (low $385.98, high $712.09) — a potential gain of +71% on today's $296.11. Momentum favours further upside here.
In 2032, BIO is projected to trade between $473.30 and $897.71, averaging $628.71 — a potential gain of +112% from today's $296.11. That is up +24% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Bio-Rad Laboratories, Inc.'s 2033 outlook centres on $665.43, within a $495.15 to $963.40 range. That is up +6% on the projected 2032 average. That marks a +125% change versus current levels. Momentum favours further upside here.
By 2034, BIO could reach as high as $1,035.34, with a base case around $706.04 and support toward $519.61 — roughly +138% from $296.11. Buyers look set to stay in control over this stretch.
Expect BIO to range from $537.71 to $1,095.68 through 2035. The $738.34 average target implies a +149% move from current prices. That is up +5% on the projected 2034 average. Momentum favours further upside here.
The BIO price prediction for 2040 points to an average of $1,161.91 (low $807.30, high $1,813.12) — a potential gain of +292% on today's $296.11. Buyers look set to stay in control over this stretch.
In 2050, BIO is projected to trade between $1,405.98 and $3,679.59, averaging $2,189.33 — a potential gain of +639% from today's $296.11. That is up +88% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in BIO today (≈ 3.377123 BIO) could be worth
$7,393.62
+$6,393.62 (+639%) by 2050 · US Dollar
Based on the average projected BIO price of $2,189.33 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BIOwould be worth at today's price.
$1,000 invested in BIO on Jul 10, 2025 (≈ 3.84793 BIO) would be worth
$1,139.41
+$139.41 (+13.9%) today · 1.14× · US Dollar
Based on a BIO entry price of $259.88 vs. today's $296.11.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $296.86 | $997.47 | -0.3% |
| 1 month ago | $291.01 | $1,017.53 | +1.8% |
| 3 months ago | $279.25 | $1,060.38 | +6.0% |
| 6 months ago | $323 | $916.75 | -8.3% |
| 1 year ago | $259.88 | $1,139.41 | +13.9% |
| All time (5.0y) ago | $673.98 | $439.35 | -56.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BIO forecast.
Our base-case forecast reaches $590.00 around 2032.
Implied market cap at $590.00: $12.8B
The multi‑year forecast points to a sustained bullish trajectory with rising averages and growing upside. For 2027 the average price is $360.31 with a forecasted ROI of 20.8 and a bullish sentiment. The 2030 average is $452.08 (min $343.52, max $638.20) with ROI 51.6 and bullish sentiment, followed by further gains: 2040 average $1,314.45 (min $884.05, max $2,117.95) ROI 340.7; 2050 average $2,495.53 (min $1,530.84, max $4,358.30) ROI 736.6 and bullish sentiment.
Earlier years show a steady climb from 2028 ($399.12 avg) through 2035 ($809.17 avg) with progressively higher targets and bullish outlooks. These figures illustrate a long‑term, optimistic trajectory, but they are estimates and not guarantees, and the forecast includes substantial upside potential alongside inherent uncertainty.
Tap a question to reveal the answer.
2030 average price $452.08; min $343.52; max $638.20; ROIPct: 51.6; sentiment: BULLISH.
The forecast shows bullish sentiment from 2027 onward with rising averages and ROI, though 2026 is Neutral with an average close to the current price. These are estimates, not guarantees.
Yes—the 2027 forecast maximum is $470.51.
2040 average price $1,314.45; min $884.05; max $2,117.95; ROIPct: 340.7; sentiment: BULLISH.
2050 average price $2,495.53; min $1,530.84; max $4,358.30; ROIPct: 736.6; sentiment: BULLISH.
Bio-Rad Laboratories, Inc. Community Discussion
0Share your Bio-Rad Laboratories, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.